Author

B. Ramms

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Physiology· 2 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:mouse· 3 Research Focus:cancer & tumor microenvironment· 2 Research Focus:host-pathogen & immune response· 2 Assay:metabolomics· 2 Assay:proteomics· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1

Frequent Co-Authors

A. R. Harrington· 2 shared D. P. Pollow· 2 shared H. Zhu· 2 shared M. Sander· 2 shared M. Wortham· 2 shared A. Hammond· 1 shared A. Quach· 1 shared A. R. Pessentheiner· 1 shared

Activity by Year

2021-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPhysiology

A. R. Harrington

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Metabolic control of adaptive β-cell proliferation by the protein deacetylase SIRT2

M. Wortham, B. Ramms, C. Zeng, J. R. Benthuysen, S. Sai, D. P. Pollow, F. Liu, M. Schlichting, A. R. Harrington, B. Liu, T. P. Prakash, E. C. Pirie, H. Zhu, S. Baghdasarian, J. Auwerx, , M. Sander

This study identifies SIRT2 as a regulator of β-cell proliferation, showing its role in controlling β-cell expansion during hyperglycemia while preserving feedback mechanisms.

bioRxiv · Feb 24, 2024 · PreprintPhysiology

Systemic LSD1 inhibition prevents aberrant remodeling of metabolism in obesity

B. Ramms, D. P. Pollow, H. Zhu, C. Nora, A. R. Harrington, I. Omar, P. Gordts, M. Wortham, M. Sander

This study shows that systemic LSD1 inhibition reduces obesity-related metabolic issues like NAFLD and improves insulin sensitivity in mice without affecting lean mice.

bioRxiv · Nov 25, 2021Physiology

The Human Milk Oligosaccharide 3-Sialyllactose Promotes Inflammation Resolution and Reduces Atherosclerosis Development in Mice.

A. R. Pessentheiner, N. J. Spann, C. A. Autran, B. Ramms, A. W. T. Chiang, K. V. Grunddal, Y. Wang, A. Quach, L. M. Booshehri, A. Hammond, C. Tognaccini, J. Latasiewicz, j. L. Witztum, H. M. Hoffman, N. E. Lewis, , P. L. S. M. Gordts

This study shows that 3-sialyllactose reduces inflammation and atherosclerosis in mice by modulating transcriptional activity in macrophages.

bioRxiv · Mar 19, 2021Immunology